Research use only
BPC-157 vs TB-500: how the two tissue-repair research peptides differ
· 4 min read
BPC-157 and TB-500 are two of the most-studied peptides in tissue-repair research, and they are frequently compared. Mechanistically they are quite different, which is exactly why they are often examined side by side.
BPC-157
BPC-157 is a synthetic 15-amino-acid peptide (a pentadecapeptide) studied for its role in angiogenic, cytoprotective and cell-signalling pathways in experimental models. Research interest centres on cell migration, extracellular-matrix interactions and vascular signalling.
TB-500
TB-500 is a synthetic fragment of thymosin beta-4. Its studied mechanism is distinct: actin regulation and cell-migration pathways. Where BPC-157 research often looks at signalling and angiogenesis, TB-500 research tends to focus on cytoskeletal dynamics.
Why they are studied together
Because the two act on complementary pathways, they are a common pairing in soft-tissue research designs - which is why the Tissue Repair Stack combines them. A related compound, GHK-Cu, a copper-binding tripeptide, is often added for matrix-remodelling research.
Research use only
These peptides are supplied for laboratory and in-vitro research only, not for human or veterinary use. See the full research disclaimer.